Responses
Regular and young investigator award abstracts
Clinical trials in progress
366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC
Compose a Response to This Article
Other responses
No responses have been published for this article.
